Abstract
Background
Changes to TNM staging criteria for breast cancer, introduced in 2003, have resulted in stage re-classification for some tumors. The most frequently implemented change has resulted in tumors associated with more than three positive axillary nodes being upstaged.We hypothesize these TNM staging changes would result in more TNM Stage IIB, IIIA, and IIIB tumors and that disease-specific survival estimates would change under the new staging system.
Methods
A review of data was completed for patients diagnosed with breast cancer between 1 January 1995 and 31 December 2000. Tumors that would have been staged differently under the 2003 system were identified and re-classified.Clinical outcomes were determined and disease-specific survival estimates were compared relative to TNM Stage using the old and new staging systems.Data were analyzed using the log-rank test and the method of Kaplan and Meier was used to generate survival curves.
Results
Data were available for 2492 tumors, of which 919 were candidates for re-classification, including 829 old Stage II, 59 old Stage III, and 31 old Stage IV. Of these 919, 159 (17%) underwent stage re-classification using the new system. Separate survival estimates for patients who had been under old stage IIA/B, IIIA/B were generated; patients upstaged from IIA or IIB demonstrated a significant difference in survival.
Conclusions
Stage specific survival curves indicated decreased survival for patients whose tumors had been upstaged from IIA or IIB under the old system; survival for all other patients remained unchanged.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Cancer Staging System. http://www.cancer.gov/cancertopics/factsheet/Detection/staging
Singletary SE, Allred C, Ashley P, et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 2002; 20:3628–3636
Gusterson BA. The new TNM classification and micrometastases. The Breast 2003; 12:387–90
De Widt-Levert LM, Tjan-Heijnen CG, bult P, Ruers TJM, Wobbes T. Stage migration in breast cancer: surgical decisions concerning isolated tumor cells and micro-metastases in the sentinel lymph node. EJSO 2003; 29:216–220
Penault-Lorca F. Comments on the new American Joint Committee on Cancer TNM staging for breast cancer.What’s new for the pathologist? Ann Pathol 2003; 23:492–5
Singletary SE, Greene FL. Revision of breast cancer staging. The 6th Edition of the TNM classification. Seminars in Surgical Oncology 2003; 21:53–59
Escobar PF, Patrick RJ, Rybicki LA, et al. Prognostic significant of residual breast disease and axillary node involvement for patients who had primary induction chemotherapy for advanced breast cancer. Ann Surg Onc Accepted for publication 10/12/2005. In press
Woodward WA, Strom EA, Tucker SL, et al. Adopting new breast cancer staging: The impact of stage migration. JCOM 2003; 10:638, 641
Woodward WA, Strom EA, Tucker SL, et al. Changes in the 2003 American Joint Committee on Cancer staging for breast cancer dramatically affect stage-specific survival
Duraker N, Caynak ZC. Prognostic value of the 2002 TNM classification for breast carcinoma with regard to the number of metastatic axillary lymph nodes. Cancer 2005; 104:700–7
Bunnell CA. Winer AP.Lumping versus splitting: The splitters take this round. JCO 2002; 20:3576–7
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Escobar, P.F., Patrick, R.J., Rybicki, L.A. et al. The 2003 Revised TNM Staging System for Breast Cancer: Results of Stage Re-classification on Survival and Future Comparisons among Stage Groups. Ann Surg Oncol 14, 143–147 (2007). https://doi.org/10.1245/s10434-006-9147-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-006-9147-0